CD38‐Specific Gallium‐68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET

Abstract The limited availability of molecularly targeted low‐molecular‐weight imaging agents for monitoring multiple myeloma (MM)‐targeted therapies has been a significant challenge in the field. In response, a first‐in‐class peptide‐based radiotracer, [68Ga]Ga‐AJ206, is developed that can be seaml...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Ajay Kumar Sharma, Kuldeep Gupta, Akhilesh Mishra, Gabriela Lofland, Ian Marsh, Dhiraj Kumar, Gabriel Ghiaur, Philip Imus, Steven P. Rowe, Robert F. Hobbs, Christian B. Gocke, Sridhar Nimmagadda
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Wiley 2024-04-01
Sarja:	Advanced Science
Aiheet:	ATRA CD38 daratumumab isatuximab PET pharmacodynamics
Linkit:	https://doi.org/10.1002/advs.202308617
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!